Title

Statistical Considerations for Clinical Trials During COVID-19: Independent DMC for Blinded Data Monitoring and Analysis

Document Type

Article

Publication Date

4-21-2020

Publication Title

LinkedIn

Abstract

To supplement both the FDA and EMA guidance, we describe the principles and key elements for developing a DMC chart for individual clinical trials affected by COVID-19.

Share

COinS